Fake job offer from Dermaxon

We have been alerted that some cybercriminals are using Dermaxon’s name and logo to lure unsuspecting job seekers into a scam. They are sending out fake emails and messages, claiming that they have a job opening for you at Dermaxon, and asking you to pay a fee...

Dermaxon received a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to demonstrate the effects of a preclinical candidate for the oral treatment of recalcitrant nodular acne.

Dermaxon, in collaboration with researchers at the University of Texas Medical Branch, is studying the neuroprotective effects of a CYP26 inhibitor under a grant sponsored by the Craig H. Neilsen Foundation.

DermaXon is proud to collaborate with researchers at the University of Texas Medical Branch on a project sponsored by the Department of Defense.

DermaXon Partners with New York Based AI company VantAI For Two Drug Development Programs

DermaXon announces its partnership with VantAI, a Roivant Biosciences Vant company, for the rapid acceleration of two of its drug development programs. VantAI leads the computational drug discovery space with technology at the bleeding edge of machine learning and...

DermaXon will be presenting at BIO 2020, NIH Innovation Zone June 8 -12, 2020